Results 311 to 320 of about 787,943 (334)

Thrombotic Events Associated with C1 Esterase Inhibitor Products in Patients with Hereditary Angioedema: Investigation from the United States Food and Drug Administration Adverse Event Reporting System Database

Pharmacotherapy, 2012
P. Gandhi, W. M. Gentry, M. Bottorff
semanticscholar   +1 more source

Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database.

Heart Rhythm, 2004
R. Hauser, Linda M. Kallinen
semanticscholar   +1 more source

Cancer statistics, 2018

Ca-A Cancer Journal for Clinicians, 2018
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal Dvm   +2 more
exaly  

United States Department of Agriculture. Food and Drug Administration

The Analyst, 1930
openaire   +1 more source

Pharmacogenomics in the Assessment of Therapeutic Risks versus Benefits: Inside the United States Food and Drug Administration

Pharmacotherapy, 2011
I. Zineh, M. Pacanowski
semanticscholar   +1 more source

United States Food and Drug Administration and Department of Defense shelf-life extension program of pharmaceutical products: progress and promise.

Journal of Pharmacy and Science, 2014
Saeed R. Khan, R. Kona, P. Faustino, Abhay Gupta, Jeb S Taylor, D. A. Porter, M. Khan   +6 more
semanticscholar   +1 more source

Cancer statistics, 2016

Ca-A Cancer Journal for Clinicians, 2016
Rebecca L Siegel, Kimberly D Miller
exaly  

Cancer statistics, 2017

Ca-A Cancer Journal for Clinicians, 2017
Rebecca L Siegel, Kimberly D Miller
exaly  

Inside the black box: current policies and concerns with the United States Food and Drug Administration's highest drug safety warning system

Current Opinion in Anaesthesiology, 2010
Kylene Halloran, P. Barash
semanticscholar   +1 more source

Cancer statistics, 2015

Ca-A Cancer Journal for Clinicians, 2015
Rebecca L Siegel
exaly